Literature DB >> 10557321

Increased thrombin responsiveness in platelets from mice lacking glycoprotein V.

V Ramakrishnan1, P S Reeves, F DeGuzman, U Deshpande, K Ministri-Madrid, R B DuBridge, D R Phillips.   

Abstract

A role for glycoprotein (GP)V in platelet function has been proposed on the basis of observations that GP V is the major thrombin substrate on intact platelets cleaved during thrombin-induced platelet aggregation, and that GP V promotes GP Ib-IX surface expression in heterologous cells. We tested the hypotheses that GP V is involved in thrombin-induced platelet activation, in GP Ib-IX expression, and in other platelet responses by generating GP V null mice. Contrary to expectations, GP V -/- platelets were normal in size and expressed normal amounts of GP Ib-IX that was functional in von Willebrand factor binding, explaining why defects in GP V have not been observed in Bernard-Soulier syndrome, a bleeding disorder caused by a lack of functional GP Ib-IX-V. Moreover, in vitro analysis demonstrated that GP V -/- platelets were hyperresponsive to thrombin, resulting in increased fibrinogen binding and an increased aggregation response. Consistent with these findings, GP V -/- mice had a shorter bleeding time. These data support a role for GP V as a negative modulator of platelet activation. Furthermore, they suggest a new mechanism by which thrombin enhances platelet responsiveness independent of activation of the classical G-protein-coupled thrombin receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557321      PMCID: PMC23948          DOI: 10.1073/pnas.96.23.13336

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane.

Authors:  P W Modderman; L G Admiraal; A Sonnenberg; A E von dem Borne
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

2.  Interaction of purified actin-binding protein with the platelet membrane glycoprotein Ib-IX complex.

Authors:  R K Andrews; J E Fox
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

Review 3.  Altering genes in animals by gene targeting.

Authors:  B H Koller; O Smithies
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

4.  Defective adhesion of platelets to subendothelium in von Willebrand's disease and Bernard-Soulier syndrome.

Authors:  H R Baumgartner; T B Tschopp; H J Weiss
Journal:  Thromb Haemost       Date:  1978-06-30       Impact factor: 5.249

5.  The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments.

Authors:  M Handa; K Titani; L Z Holland; J R Roberts; Z M Ruggeri
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

Authors:  V L Tybulewicz; C E Crawford; P K Jackson; R T Bronson; R C Mulligan
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

8.  Glycoprotein V is not the thrombin activation receptor on human blood platelets.

Authors:  D Bienz; W Schnippering; K J Clemetson
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

9.  Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib.

Authors:  V Vicente; P J Kostel; Z M Ruggeri
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

10.  Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.

Authors:  R K Andrews; W J Booth; J J Gorman; P A Castaldi; M C Berndt
Journal:  Biochemistry       Date:  1989-10-17       Impact factor: 3.162

View more
  20 in total

1.  A new "kid" on the platelet thrombin receptor "block": glycoprotein Ib-IX-V.

Authors:  G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome.

Authors:  J Ware; S Russell; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 3.  14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling.

Authors:  Yunfeng Chen; Zaverio M Ruggeri; Xiaoping Du
Journal:  Blood       Date:  2018-04-05       Impact factor: 22.113

4.  Bernard-Soulier syndrome.

Authors:  Michael C Berndt; Robert K Andrews
Journal:  Haematologica       Date:  2011-03       Impact factor: 9.941

5.  Is the mysterious platelet receptor GPV an unsuspected major target for platelet autoantibodies?

Authors:  Paquita Nurden; Alan T Nurden
Journal:  Haematologica       Date:  2019-06       Impact factor: 9.941

6.  A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V.

Authors:  V Ramakrishnan; F DeGuzman; M Bao; S W Hall; L L Leung; D R Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 7.  Platelet receptors and signaling in the dynamics of thrombus formation.

Authors:  José Rivera; María Luisa Lozano; Leyre Navarro-Núñez; Vicente Vicente
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

Review 8.  Dysfunctional platelet membrane receptors: from humans to mice.

Authors:  Jerry Ware
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

Review 9.  The organizing principle of the platelet glycoprotein Ib-IX-V complex.

Authors:  R Li; J Emsley
Journal:  J Thromb Haemost       Date:  2013-04       Impact factor: 5.824

10.  Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein.

Authors:  Paul A Reynolds; Gromoslaw A Smolen; Rachel E Palmer; Dennis Sgroi; Vijay Yajnik; William L Gerald; Daniel A Haber
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.